Centivax
Centivax45
About
What does Centivax do?
Centivax is a clinical-stage company focused on developing broad-spectrum vaccines to combat infectious diseases. Their lead candidate is a broad-spectrum influenza vaccine currently in Phase 1 clinical development. The company's mission is to "smash the mutants" and accelerate the world's transition to a post-pathogen humanity. They were featured in the Netflix docuseries "Pandemic: How to Prevent an Outbreak" and received a Gates Foundation Grand Challenge award for their work on pandemic thre…
What is Centivax's revenue?
StartupHub estimates Centivax's annual revenue at $3.2M (range $1.8M to $11.6M, 69% confidence), based on comparable companies in the sector.
Where is Centivax headquartered?
Centivax is headquartered in South San Francisco, California, USA.
What industry does Centivax operate in?
Centivax operates in Biotechnology, Pharmaceuticals, Vaccines, Infectious Diseases.
How many employees does Centivax have?
Centivax has approximately 31 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.